Vertex to Buy Crinetics for $10 Billion to Expand Endocrinology Focus
2026-07-06 20:25:16
Vertex Pharmaceuticals Inc. agreed to buy Crinetics Pharmaceuticals Inc. for $10 billion in cash as it expands into endocrinology, including medicines for acromegaly and hormone disorders, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
